Return to search

Digital biology firm Recursion racks up $239m Series D

Salt Lake City-based Recursion, a digital biology company, has secured $239 million in Series D financing.

Salt Lake City-based Recursion, a digital biology company, has secured $239 million in Series D financing. Leaps by Bayer, the impact investment arm of Bayer AG, led the round.

Source: Press Release